Ultragenyx Pharmaceutical Sales More Than Triple, Pares Losses

Ultragenyx Pharmaceutical Sales More Than Triple, Pares Losses

Ultragenyx Pharmaceutical posted third-quarter results late Tuesday that beat views on the top and bottom lines after RARE stock hit a nearly five-year high, revenue more than triples.